Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial

Juan Li, Hui Zheng, Ling Zhao, Ying Li, Yan Zhang, Xiao-rong Chang, Rui-hui Wang, Jing Shi, Jin Cui, Yin-lan Huang, Xiang Li, Jie Chen, De-hua Li, Fan-rong Liang, Juan Li, Hui Zheng, Ling Zhao, Ying Li, Yan Zhang, Xiao-rong Chang, Rui-hui Wang, Jing Shi, Jin Cui, Yin-lan Huang, Xiang Li, Jie Chen, De-hua Li, Fan-rong Liang

Abstract

Background: Several studies using acupuncture to treat essential hypertension have been carried out. However, whether acupuncture is efficacious for hypertension is still controversial. Therefore, this trial aims to evaluate the efficacy and safety of acupuncture for patients with mild hypertension.

Methods/design: This is a large scale, open-label, multicenter, randomized controlled clinical trial with four parallel arms. We will recruit 428 hypertensive patients with systolic blood pressure (SBP) between 140 and 159 mmHg, diastolic blood pressure (DBP) between 90 and 99 mmHg. The participants will be randomly assigned to four different groups (three acupuncture groups and one waiting list group) (1).The affected meridian acupuncture group (n = 107) is treated with acupoints on the affected meridians (2).The non-affected meridian acupuncture group (n = 107) is treated with acupoints on the non-affected meridians (3).The invasive sham acupuncture group (n = 107) is provided with sham acupoints treatment (4).The waiting-list group (n = 107) is not offered any intervention until they complete the trial. Each patient allocated to acupuncture groups will receive 18 sessions of acupuncture treatment over 6 weeks. This trial will be conducted in 11 hospitals in China. The primary endpoint is the change in average 24-hSBP before and 6 weeks after randomization. The secondary endpoints are average SBP and average DBP during the daytime and night-time, and 36-Item Short Form Survey (SF-36), and so on.

Discussion: This is the first large scale, multicenter, randomized, sham controlled trial of acupuncture for essential hypertension in China. It may clarify the efficacy of acupuncture as a treatment for mild hypertension.

Trial registration: Clinicaltrials.gov Identifier: NCT01701726.

Figures

Figure 1
Figure 1
Trial flow chart.
Figure 2
Figure 2
Locations of acupoints: affected meridian acupuncture group (AMA).
Figure 3
Figure 3
Locations of acupoints: non-affected meridian acupuncture group (NMA).
Figure 4
Figure 4
Locations of non-acupoints: invasive sham acupuncture group (ISA).

References

    1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–223.
    1. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension. 2007;49:69–75. doi: 10.1161/01.HYP.0000252676.46043.18.
    1. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K. Heart disease and stroke statistics–2009 update a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation. 2009;119:480–486.
    1. Li LM, Rao KQ, Kong LZ, Yao CH, Xiang HD, Zhai FY, Ma GS, Yang XG. A description on the Chinese national nutrition and health survey in 2002. Chin J Epidemiol. 2005;26:478–484.
    1. Liu LS. Chinese guidelines for management of hypertension. Chin J Hypertens. 2010;2011(19):701–708.
    1. Wang J-G, Li Y. Characteristics of hypertension in the Chinese population. Curr Hypertens Rep. 2012;14:410–415. doi: 10.1007/s11906-012-0288-1.
    1. Zhai Y, HU JP, Kong LZ, Zhao WH, Chen CM. Economic burden of coronary heart disease and stroke attributable to hypertension in China. Chin J Epidemiol. 2006;27:744–747.
    1. Diao D, Wright JM, Cundiff DK, Gueyffier F. Pharmacotherapy for mild hypertension. Cochrane Database Syst Rev. 2012;8:CD006742.
    1. Lin MC, Nahin R, Gershwin ME, Longhurst JC, Wu KK. State of complementary and alternative medicine in cardiovascular, lung, and blood research: executive summary of a workshop. Circulation. 2001;103:2038–2041. doi: 10.1161/01.CIR.103.16.2038.
    1. Richter A, Herlitz J, Hjalmarson A. Effect of acupuncture in patients with angina pectoris. Eur Heart J. 1991;12:175–178. doi: 10.1093/eurheartj/12.suppl_D.175.
    1. Zhou W, Longhurst JC. Neuroendocrine mechanisms of acupuncture in the treatment of hypertension. Evid Based Complement Altern Med. 2011;2012:878673.
    1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206–1252. doi: 10.1161/01.HYP.0000107251.49515.c2.
    1. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S. Guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) Eur Heart J. 2007;2007(28):1462–1536.
    1. WHO Regional Office for the Western Pacific. WHO standard acupuncture point locations in the western pacific region. Manila: WHO; 2008.
    1. Li Y, Zheng H, Witt CM, Roll S, Yu S-g, Yan J, Sun G-j, Zhao L, Huang W-j, Chang X. Acupuncture for migraine prophylaxis: a randomized controlled trial. Can Med Assoc J. 2012;184:401–410. doi: 10.1503/cmaj.110551.
    1. Zhou W, Fu L-W, Tjen-A-Looi SC, Li P, Longhurst JC. Afferent mechanisms underlying stimulation modality-related modulation of acupuncture-related cardiovascular responses. J Appl Physiol. 2005;98:872–880.
    1. Zhou W, Tjen-A-Looi SC, Longhurst JC. Brain stem mechanisms underlying acupuncture modality-related modulation of cardiovascular responses in rats. J Appl Physiol. 2005;99:851–860. doi: 10.1152/japplphysiol.01365.2004.
    1. Health Quality Ontario. Twenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis. Ont Health Technol Assess Ser. 2012;12:1–65.
    1. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407–2415. doi: 10.1056/NEJMoa022273.
    1. Verdecchia P, Schillaci G, Reboldi G, Franklin SS, Porcellati C. Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation. 2001;103:2579–2584. doi: 10.1161/01.CIR.103.21.2579.
    1. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Pede S, Porcellati C. Ambulatory pulse pressure a potent predictor of total cardiovascular risk in hypertension. Hypertension. 1998;32:983–988. doi: 10.1161/01.HYP.32.6.983.
    1. Bastos J, Bertoquini S, Silva J, Polonia J. Relationship between ambulatory blood pressure monitoring values and future occurrence of ischemic cerebrovascular and coronary events in hypertensive patients. Rev Port Cardiol. 2006;25:305.
    1. Fang JQ. Quality of life measurement method and application. Peking University Medical Press; 2000.
    1. Wang CH, Fang JQ, Tang XL, Zhang CZ, Lu YB, Meng Q, Gao L. The effect evaluation on measuring quality of life in patients with liver cancer by SF-36 scale. Tumor. 2005;25:492–494.
    1. Wang CH, Fang JQ, Shi ML, Chen LY, Zhang YZ. A comparative study on measuring quality of life for drug addicts by SF-36 scale. Chin J Behav Med Sci. 1998;7:260–261.
    1. Flachskampf FA, Gallasch J, Gefeller O, Gan J, Mao J, Pfahlberg AB, Wortmann A, Klinghammer L, Pflederer W, Daniel WG. Randomized trial of acupuncture to lower blood pressure. Circulation. 2007;115:3121–3129. doi: 10.1161/CIRCULATIONAHA.106.661140.
    1. Liang F, Fang Z, Zhao L, Tang Y. Specificity of acupoint effects and its fundamental laws. Zhongguo Zhen Jiu. 2009;29:129.
    1. Ding XY, She YF, Ma LX, Zhu J. Three basic characteristics of specificity of acupoint effect. China J TradiChin Medic Pharma. 2010;25:1356–1359.
    1. Choi EM, Jiang F, Longhurst JC. Point specificity in acupuncture. Chin Med. 2012;7:1–5. doi: 10.1186/1749-8546-7-1.
    1. Zhao L, Chen J, Liu C-Z, Li Y, Cai D-J, Tang Y, Yang J, Liang F-R. A review of acupoint specificity research in china: status quo and prospects. Evid Based Complement Alter Medic. 2012;2012:543943.
    1. Yin C, Seo B, Park H-J, Cho M, Jung W, Choue R, Kim C, Park H-K, Lee H, Koh H. Acupuncture, a promising adjunctive therapy for essential hypertension: a double-blind, randomized, controlled trial. Neurol Res. 2007;Suppl 1:98–103.
    1. Kalish LA, Buczynski B, Connell P, Gemmel A, Goertz C, Macklin EA, Pian-Smith M, Stevens S, Thompson J, Valaskatgis P. Stop hypertension with the acupuncture research program (SHARP): clinical trial design and screening results. Control Clin Trials. 2004;25:76–103. doi: 10.1016/j.cct.2003.08.006.
    1. The National Heart, Lung, and Blood Institute Working Group on Future Directions in Hypertension Treatment Trials. Major clinical trials of hypertension: what should be done next? Hypertension. 2005;46:1–6.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj